Day 1 Tuesday, May 6
7:30-8:20 Mentoring Breakfast-Event Hall (Academic Careers)
Jin Wang, Baylor College of Medicine
Reid Powell, Institute of Biosciences and Technology, Texas A&M University
Suzanne Tomlinson-Mathis, Gulf Coast Consortia
8:30 am Welcome
Suzanne Tomlinson-Mathis, Gulf Coast Consortia
Keynote Introduction Mohanad Albayyaa, Univ of Texas Medical Branch at Galveston
8:35-9:10 Keynote Presentation
Statistical Significance for Causal Inference: How Decision Makers Hijacked Science
Miguel Hernán, Harvard University
Session 1 Preclinical to Clinical: Observed Translational Differences
Moderator Scott Widmann, Texas Southern University
9:10 When Humans Do Not Behave Like Lab Animals
Jeff Larson, Tvardi Therapeutics
9:30 Leveraging Clinical Data to Reimagine Novel Therapies for Stem Cell Transplant
Siddhartha De, 7Hills Pharma
9:50 Panel Discussion
Siddhartha De, 7Hills Pharma
Jeff Larson, Tvardi Therapeutics
Elaine Lea-Chou, ELC Private Consulting
Reid Powell, Institute of Biosciences and Technology, Texas A&M University
10:30 Vendor Session and Networking Break-Event Hall
Session 2 Real World Evidence to Inform Preclinical Development
Moderator Mohanad Albayyaa, University of Texas Medical Branch, Galveston
11:00 Clinical Trials and Registries: Driving Scientific Innovation and Medical Breakthroughs
Wissam Khalife, University of Texas Medical Branch at Galveston
11:20 How Early Data Can Help Determine Future Study Designs
Long Doan, SpyGlass Pharma Inc.
11:40 Panel Discussion
Lynda Chin, Apricity Health Inc.
Long Doan, SpyGlass Pharma Inc.
George Golovko, University of Texas Medical Branch
Wissam Khalife, University of Texas Medical Branch at Galveston
Moderator Dillon Fritz, GCC Research Evaluation and Commercialization Hub
12:15 Rapid Fire Presentations- even-numbered posters
Digital Spatial Profiling Identifies Novel Targets in Patients with Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension
Phoebe Andrew, University of Texas Health Science Center, Houston, Poster 6
Investigating the Role of SSRIs’ as a Potential Therapeutic for Neurodegenerative Diseases
Olivia Reed, Rice University, Poster 4
Two-Pronged Precision: Evaluating a Novel Dual-Targeting Antibody-Drug-Conjugate Based Therapy to Combat Colorectal Cancer
Shraddha Subramanian, MD Anderson Cancer Center, Poster 2
12:30 Lunch and even-numbered posters – Event Hall
12:30-1:30 Lunch
1:30-2:30 Poster presentations, even-numbered posters
Session 3 Innovative Methods for Identifying New Targets
Moderator Scott Gilbertson, University of Houston
2:30-2:50 Phenotypic Drug Discovery Revisited
Deepak Nijhawan, University of Texas Southwestern
2:50-3:10 Discovery of Novel First-in-Class Medicines with a Suite of AI-Enabled Platform Technologies
Aimee Iberg, Recursion Pharmaceutical
3:10-3:50 Panel Discussion
Dillon Fritz, GCC Research Evaluation and Commercialization Hub
Matthew Gibson, Hogan Lovells
Aimee Iberg, Recursion Pharmaceutical
Elaine Lea-Chou, ELC Private Consulting
Deepak Nijhawan, University of Texas Southwestern
Reid Powell, Institute of Biosciences and Technology, Texas A&M University
Session 4 Houston-Based Resources for Healthcare Innovation
Moderator Suzanne Tomlinson-Mathis, Gulf Coast Consortia
3:50 Jennifer Roohi, TMC Innovation
3:55 Lacey Tezino, GCC Research Evaluation and Commercialization Hub
4:00 Colby Suire, K2 Bio
4:05 Allison Rhines, Johnson & Johnson Innovation, JLABS TMC
4:10 Zach Hightower, Portal Innovation
4:15 Will Tankersley, Levit Green
4:20 Jeffrey Wade, BioHouston
4:25 Megan Liles, HGI Clinical
4:30 Atul Varadhachary, Fannin Innovation
4:35 David Maxwell, CanSAR platform/MD Anderson Cancer Center
4:40-6:00 Reception and BioConnect-Pre-Function
Day 2 Wednesday, May 7
8:00-8:50 am Mentoring Breakfast-Event Hall (Industry Careers)
Nassim Beiranvand, Texas Medical Center, Accelerator for Cancer Therapeutics
Jason Cross, MD Anderson Cancer Center
David Kummer, MD Anderson Cancer Center
Keynote Introduction Suzanne Tomlinson-Mathis, Gulf Coast Consortia
9:00 Keynote Presentation
The Fun of Academic Drug Discovery – Novel Targets, New Technologies
Michelle Arkin, University of California, San Francisco
Session 5 New Therapeutic Strategies
Moderator Reid Powell, Institute of Biosciences and Technology, Texas A&M University
9:35 New Strategies for Small Molecule Development
Stanton McHardy, University of Texas, San Antonio
9:55 New Strategies for Antibody Drug Modalities
Chen-Ni Chin, IGM Biosciences, Inc.
10:20 Panel Discussion
Bissan Al-Lazikani, MD Anderson Cancer Center
Cheryl Beal Anderson, ACE Regulatory Affairs Consulting
Chen-Ni Chin, IGM Biosciences, Inc.
Matthew Gibson, Hogan Lovells
Stanton McHardy, University of Texas, San Antonio
11:00 Vendor Session and Networking Break-Event Hall
Session 6 GCC IDDD Core Network Showcase
Moderator Suzanne Tomlinson-Mathis, Gulf Coast Consortia
11:30 GCC IDDD Core Network
Suzanne Tomlinson-Mathis, Gulf Coast Consortia
11:40 GCC Drug Discovery Resource Center
Cliff Stephan, Texas A&M Institute of Bioscience and Technology
11:50 GCC Center for Comprehensive PK/PD and Formulation
Dong Liang, Texas Southern University
11:55 Center for Innovative Drug Discovery
Stanton McHardy, University of Texas San Antonio
12:00 Advanced Protein Therapeutics
Jennifer Maynard, University of Texas
12:05 Advanced Cancer Antibody Drug Modalities Core
Zhiqiang An, University of Texas Health Science Center, Houston
12:10 Preclinical Development Core for Large Molecules
Qingyun “Jim” Liu, University of Texas Health Science Center, Houston
12:15 Accelerator for Cancer Therapeutics
Supriya Sinha, TMC Innovation
12:20 Targeted Therapeutics Drug Discovery and Development
Kevin Dalby, University of Texas
Moderator Dillon Fritz, GCC Research Evaluation and Commercialization Hub
12:25 Rapid Fire Presentations, odd-numbered posters
Expanding the IMiD-induced CRBN Degradome: Identifying Novel Neosubstrates of Molecular Glue Degraders Using Proximity-based Proteomics
Adebowale Alade, Baylor College of Medicine, Poster 1
Intratumoral biodegradable-Nanofluidic Platform for Localized Multimodal Immunotherapy Enhances Tumor Eradication and Immune Memory
Francesco Manfredi, Houston Methodist Research Institute, Poster 5
12:35 Lunch and odd-numbered posters-Event Hall
12:35-1:30 Lunch
1:30-2:30 Poster presentations, odd-numbered posters
Session 7 Innovative Medical Devices
Moderator Jiaxin Feng, Texas A&M University
2:30 Precision Medicine at 3 A.M.
Onur Kilic, Bairitone Health
2:50 Leveraging Wearable Devices to Monitor Disease Progression and Acute Events in Stroke Patients
Sandra Saldana, Alva Health
3:10 Panel Discussion
Kevin Coker, MD Anderson Cancer Center
Abbas Dhilawala, Galendata
Mohammad Ghasemi Rad, Baylor College of Medicine
Gabrielle Guttman, TMC Venture Fund
Onur Kilic, Bairitone Health
Meagan Pitcher, Bairitone Health
Sandra Saldana, Alva Health
4:00 Closing Remarks